A recent study into Parkinson’s disease has shown that a stool transplant may constitute a new and valuable treatment of the disease. “It offers a potentially safe, effective and cost-efficient way of alleviating the symptoms and improving the quality of life of millions. A 'bacterial pill' might replace the stool transplant in the future. But more research is needed.”
Six months ago, Anja Peumans made the decision: she changed her will so that part of her inheritance would go to the Ghent University Animal Clinic. “I felt like a weight had been lifted from my shoulders. Finally, I thought, I can fulfil my dream after I am gone”.
De ziekte van Alzheimer, frontotemporale dementie en ALS zijn verwoestende neurodegeneratieve ziekten zonder uitzicht op herstel. UGent-professor Bart Dermaut, klinisch geneticus en arts, realiseert met zijn wetenschappelijk onderzoek een doorbraak die toekomstige therapieën een nieuwe richting kan uitsturen. Mede dankzij schenkingen en erfenissen van patiënten.
Cancer researcher Celine Everaert is currently developing an important test that should help to improve treatment for cancer patients. This is possible because of a scholarship, funded by donations and bequests.
Few people have heard of it: peritoneal cancer. However, the disease, especially as a metastasis of another cancer, affects many patients. Unfortunately, it is often too late once the diagnosis is made: existing treatments achieve very little. Groundbreaking research by Professor Wim Ceelen is now resulting in new and promising treatments. And all thanks to the inheritance of a former patient.
Marleen Temmerman has long been recognised as a global authority on the subject of women’s rights and -healthcare, due to her unwavering fight to promote them. Now, she has been elected a brand-new member of the National Academy of Medicine in further recognition of outstanding achievements. As the first Belgian female in history.
After his mother passed away, Aurèle De Vos decided to commemorate his mother by establishing a fund and donating to the Botanical Garden. Its purpose is to help the Botanical Garden protect rare and endangered plants.
Only forty per cent of assistance dogs in training actually end up becoming a proper assistance dog. This problem not only causes long waiting lists, it also costs a lot of money. A collaboration, in the form of a professorship between professor Bart Broeckx and the non-profit organisation Purpose Dogs aims to find a solution.
Olexiy Lyamtsev works at the Faculty of Science at the moment. There, he is a beekeeper at Honeybee Valley, a research group led by Professor Dirk de Graaf which focuses on the declining bee population in the wild. Besides this, he is also charged with making an inventory of the museum collection at the Eva Crane Trust, a knowledge centre for beekeeping.
He is one of the most defining characters in the history of Ghent University. His name was recently given to a foundation, set up by professors Marc Cools and Christophe Vandeviver. They believe that Nico Gunzburg is the perfect embodiment of what they are keen to achieve with the foundation.
Cysticercosis is a little-known disease, which can lead to epilepsy and much worse. Annually, it causes the death of 28,000 people. Particularly in Africa, although it is discovered here too on some occasions. Pork tapeworm is the culprit. Professor Sarah Gabriël and her team are tackling this tapeworm and the havoc it causes. “However, everything depends on the governments’ resources and priorities.”
Vertical farming is booming, and above all in an urban context, since this method requires less space in order to grow sufficient food for a large number of people. Vertical farming is an agricultural concept where crops are grown in a tall greenhouse, in vertically stacked layers. The plants are not planted in earth; instead, they are cultivated in nutrient-enriched water. Artificial light is needed to ensure that the plants receive enough light in order to grow. But which sort of light gives the best result? This is the focus of one of the studies by a team of bio-engineers from Ghent University.
